Detection HBsAg mutants by immunoassays

Journal of Medical Virology

Volumn 79, Issue SUPPL. 1, 2007, Pages

  Thoai, Duong Ly ^a,b  

^a Laboratoire Claude Levy   (France)

^b Laboratoire LCL   (France)

Author keywords

HBsAg mutant; Immunoassay

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY;

AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EPITOPE MAPPING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MOLECULAR RECOGNITION; NONHUMAN; RISK REDUCTION; S GENE; VIRUS DETECTION; VIRUS GENE; VIRUS MUTATION;

HEPATITIS B VIRUS;

EID: 34748881860     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20966     Document Type: Conference Paper

References (15)

1. Coleman PF. 2006. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 12:198-203.
2. Coleman PF, Chen YC, Mushahwar IK 1999. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24.
3. Hsu HY, Chang MH, Ni YH, Chen HL. 2004. Survey of hepatitis B surface variant infection in children after a nationwide vaccination programme in Taiwan. Gut 53:1499-1503.
4. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo P, Kay A. 2004. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 73:508-515.
5. Kao JH, Chen DS. 2002. Global control of hepatitis B virus. Lancet Infect Dis 2:395-403.
6. La'ulu SL, Roberts WL. 2006. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 125:748-751.
7. Levicnic-Stezinar S. 2004. Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab 50:49-51.
8. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Férey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. 2006. Sensitivities of Four New Commercial Hepatitis B Virus Surface Antigen (HBsAg) Assays in Detection of HBsAg Mutant Forms. J Clin Microbiol 44:2321-2326.
9. Moerman B, Moons V, Sommer H, Schitt Y, Stetter M. 2004. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 50:159-162.
10. Scheiblauer H, Soboll H, Nick S. 2006. Evaluation of 17 CE-Marked HBsAg Assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 78:S66-S70.
11. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P. 2000. Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60:113-121.
12. Tallo T, Norder H, Tefanova V, Krispin T, Priimagi L, Mukomolov S, Mikhailov M, Magnius LO. 2004. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol 74:221-227.
13. Weber B. 2005. Genetic variability of the S gene of hepatitis B virus: Clinical and diagnostic impact. J Clin Virol 32:102-112.
14. Weber B, Van der Taelem-Brulé N, Berger A, Simon F, Geudin M, Ritter J. 2006. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra. J Virol Methods 135/1:109-117.
15. Zuckerman J, Zuckerman A. 2003. Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75-78.